top of page
Lucid

Our DiaComp pilot grant was selected for funding

Our pilot award to DiaComp was selected for funding! The goal of this pilot study is to test novel podocyte protective compounds that emerged from a phenotypic screen in an animal model of diabetic kidney disease


17 views0 comments

Recent Posts

See All

New lab members power up our drug discovery operation

Colin Kelley (ex. NCATS) and Omar El-wardany (practicing neurosurgeon) have joined our team and will help us power up our drug discovery operations. Colin will lead some of our screening work while Om

Rachel won Oustanding Research Recognition Award!

Super proud of our post doc Rachel Njeim for winning Oustanding Research Recognition Award at the International Podocyte Conference 2023. Next stop, small molecule therapeutic candidate for Diabetic K

Comments


bottom of page